Journal Information
Vol. 32. Issue 6.
Pages 285-301 (June - July 1996)
Share
Share
Download PDF
More article options
Vol. 32. Issue 6.
Pages 285-301 (June - July 1996)
Full text access
Normativa sobre diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica
Visits
...
T. Montemayor*
I. Alfajeme, C. Escudero, J. Morera, L. Sánchez Agudo, Grupo de Trabajo de la SEPAR.
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
American Thoracic Society.
Standares tbr the diagnosis and care oí patients with chronic obstructie pulmonary disease (COPD) and asthma.
Am Rev Respir Dis, 136 (1987), pp. 225-244
[2.]
National Heart, Lung, Blood Institute, División of Lung Diseases Worshop Report.
The definition of emphysema.
Am Rev Respir Dis, 132 (1985), pp. 182-185
[3.]
Ciba Guest SyiTiposium Report.
Terminology, definitions of ch ronic pulmonary emphysema and related conditions.
Thorax, 14 (1959), pp. 286-299
[4.]
J.W. Ramsdell, F.J. Nachtemy, K.M. Moser.
Bronchial hyperreaclivity in chronic obstructive bronchitis.
Am Rev Respir Dis, 126 (1982), pp. 829-832
[5.]
W.M. Thuribeck.
Chronic airflow obstruction.
Pathology of the lung., pp. 519-575
[6.]
US., Department of Health, Human Services Chronic Obstruc tive Lung Disease.
The health consequences of smoking. A re pon of the surgeon General Rockville, (1984),
[7.]
M. Linden, J.B. Rasmussen, E. Piiyulainen, et al.
Airwau inflammation in smokers with nonobstructive and obstructive chronic bronchitis.
Am Rev Respir Dis, 148 (1993), pp. 1.226-1.232
[8.]
M. Saetta, A. Di Stefano, P. Maestrelli, et al.
Airway eosinophilia in chronic bronchitis during exacerbations.
Am J Respir Crit Care, 150 (1994), pp. 1.646-1.650
[9.]
W.M. Thurlbeck.
Pathophysiology of chronic obstructive pulmo nary disease.
Clin Chest Med, 11 (1990), pp. 389-403
[10.]
W.M. Thurbeck.
Pathophysiology of chronic airflow obstruction.
Chest, 97 (1990), pp. 6-10
[11.]
R.R. Anthonisen, H. Bass, A. Oriol, et al.
Regional lung fuction in patients with chronic bronchitis.
Clin Sci, 35 (1968), pp. 494
[12.]
A.F. Hogg, P.T. Mackiem, W.M. Thuribeck.
Site and nature of air way obstruction in chronic obstructive lung disease.
N Engl J Med, 278 (1968), pp. 1.355-1.360
[13.]
D.S. McCarthy, R. Spencer, R. Greene, et al.
Measurement of closing volume as a simple and sensitive test for early detection of small airway disease.
Am J Med, 52 (1972), pp. 742
[14.]
A.S. Buist, B.B. Ross.
Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction.
Am Rev Respir Dis, 103 (1973), pp. 1.078
[15.]
E.R. McFadden Jr., D.A. Linden.
A reduction in maximal mid-expiratory fow rate, a spirographic manifestation of small airway di sease.
Am J Med, 52 (1972), pp. 725
[16.]
A.J. Woolcok, N.J. Vincent, P.T. Macklem.
Frequency dependence of compliance as test for obstruction in the small airways.
J Clin Invest, 48 (1969), pp. 1.097
[17.]
D.C. Stanescu, D.O. Rodenstein, C. Hoenen, et al.
Sensitive tests are poor predictors of the decline in torced expiralory volume in one second in middle aged smokers.
Am Rev Respir Dis, 135 (1987), pp. 585-590
[18.]
A.S. Buist, W.M. Vollmer, L.R. Johnson, et al.
Does the single-breath N2 test identify the smokers who will develop chronic airflow limitation?.
Am Rev Respir Dis, 137 (1988), pp. 293-301
[19.]
M. Saetta, J.L. Izquierdo, W.D. Kim, et al.
Centrilobular and panacinar emphysema ¡n smokers.
Two different diseases. Am Rev Respir Dis, 141 (1990), pp. 713
[20.]
M.G. Cosió, H. Chezzo, J.C. Hogg, et al.
The relation between structural changes in small airways and pulmonary fuction tests.
N Engl J Med, 298 (1978), pp. 1.277-1.281
[21.]
R.S. Mitchell, R.E. Stanford, J.M. Johnson, et al.
The morphologic features of the bronchi, bronchioles, and alveoli in chronic obs truction. A clinicopathologic study.
Am Rev Respir Dis, 114 (1976), pp. 137-145
[22.]
A. Nagai, W.W. Wesi, W.M. Thuribeck.
National Institutes of Health intermittent positive-pressure breathing Irial: pathology studies II. Correlation between morphologic finginds, clinical finginds, and evidence of expiratory airflow obstruction.
Am Rev Respir Dis, 132 (1985), pp. 946-953
[23.]
N.R. Anthonisem, J. Manfreda, C.P.W. Warren.
Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease.
Ann InternMed, 106 (1987), pp. 196-204
[24.]
R.G. Badgett, D.J. Tamaka, D.K. Hunt, et al.
Can modérate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone?.
Am J Med, 94 (1993), pp. 188-196
[25.]
N.K. Burki.
Roentgenologic diagnosis of emphysema.
Chest, 95 (1989), pp. 1.178-1.179
[26.]
P.C. Pratt.
Role of conventional chest radiography in diagnosis and exclusion of emphysema.
Am J Med, 82 (1987),
[27.]
K.G. Chetty, S.E. Brown, R.W. Light.
Identification of pulmonary hypertension in chronic obstructive pulmonary disease from routine chest radiographs.
Am Rev Respir Dis, 126 (1982), pp. 338-341
[28.]
W.M. Thuribeck, G. Simón.
Radiographic appearance of the chest in emphysema.
Am J Roentgenol, 130 (1978), pp. 429-440
[29.]
T.M. Nicklaus, D.W. Stomell, W.R. Christiansen, et al.
The accuracy of roent-genologic diagnosis of chronic pulmonary emphysema.
Am Rev Respir Dis, 93 (1966), pp. 889-899
[30.]
C.J. Bergin, N.L. Muller, R.R. Miller.
CT in the quantitative assessment of emphysema.
J Thorac Imaging, 1 (1986), pp. 94-103
[31.]
W.L. Foster Jr., P.C. Pratt, V.L. Roggli, et al.
Centrilobular emphyse ma. CT pathogenic correlation.
[32.]
R.R. Miller, R.L. Muller, S. Vedal, et al.
Limitations of computed tomography in the assessment of emphysema.
Am Rev Respir Dis, 139 (1989), pp. 980-983
[33.]
K. Kumano, K. Matsuba, T. Ikeda, et al.
The diagnosis of mild emphysema. Correlation of computed tomography and pathology scores.
Am Rev Respir Dis, 141 (1990), pp. 169-178
[34.]
M.K. Kinsella, N.L. Muller, R.T. Abboud, et al.
Quantitation of emphy sema by computed tomography using a density mask program and correlation with pulmonary function tests.
Chest, 97 (1990), pp. 315-321
[35.]
American Thoracic Society.
Standardization of spirometric.
Am Rev Respir Dis, 136 (1987), pp. 1.285-1.298
[36.]
Sociedad Española de Patología Respiratoria (SEPAR).
Normati va para la espirometría forzada.
Ed. Doyma, (1985),
[37.]
P.H. Quanjer, G.J. Tammeling, J.E. Cotes, et al.
Lung volumes and torced ventilatory flows.
Eur Respir J, 6 (1993), pp. 5-40
[38.]
D.V. Bate, P.T. Macklem, R.V. Christie.
Respiratory function in di sease.
2.a ed., W.B. Saunders, (1971),
[39.]
R. Carter, B. Nicotra, W. Blevins, et al.
Altered exercise gas exchange and cardiac function in patients with mild chronic obs tructive pulmonary disease.
Chest, 103 (1993), pp. 745-750
[40.]
M. Weisman, R.J. Zeballos.
Clinical excercise testing.
Clin Chest Med, 15 (1994), pp. 2
[41.]
American Thoracic Society.
Evaluation of impairment/disability secondary lo respiratory disorders.
Am Rev Respir Dis, 133 (1986), pp. 1.205
[42.]
J.E. Cotes, Rating respiratory disability: a report on behalf of a working group of the European Society for clinical respiratory physiology.
Eur Respir J, 3 (1990), pp. 1.074
[43.]
F. Ortega, T. Montemayor, A. Sánchez, et al.
Role of cardiopulmonary exercise testing and the criteria used to determine disability in patients with severe chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 150 (1994), pp. 747-751
[44.]
T. Montemayor.
Oxigenoterapia en esfuerzo en la enfermedad pulmonar obstructiva crónica [tesis doctoral].
Universi dad de Sevilla, (1989),
[45.]
N.C. Dean, J.K. Brown, J.J. Doherty, et al.
Oxigen may improve dyspnea and endurance in patients with chronic obstructive pul monary disease and only mild hypoxemia.
Am Rev Respir Dis, 146 (1992), pp. 941-945
[46.]
E.M. Gilbreth, I.M. Weisman.
Role of exercise tress testing in preoperative evaluation of patients for lung resection.
Clin Chest Med, 15 (1994), pp. 389-403
[47.]
T.J. Williams, G.A. Patterson, P.A. McClean, et al.
Maximal exercise testing in single and double lung transplant recipients.
Am Rev Respir Dis, 145 (1992), pp. 101-105
[48.]
C.R. McGacin, S.P. Gupta, G.J.R. Machardy.
Twelve minute walking test for asessing disability in chronic bronchitis.
Br Med J, 1 (1976), pp. 822-823
[49.]
S.J. Singh, M.D.L. Morgan, S.H. Scott, et al.
Development of a shuttle walking test of disability in patients with chronic airways obstruction.
Thorax, 47 (1992), pp. 1.019-1.024
[50.]
E.C. Fletcher, J. Miller, G.W. Divine, et al.
Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tensión above 60 mmHg.
Chest, 92 (1987), pp. 604-608
[51.]
N.J. Douglas, D.C. Flenley.
State of the art. Breathing during steep in patients with obstructive lung disease.
Am Rev Respir Dis, 141 (1990), pp. 1.050-1.070
[52.]
M.J. Tobin.
Respiratory muscles in disease.
Clin Chest Med, 9 (1988), pp. 263-286
[53.]
C. Shindoh, W. Hida, Y. Kikuchi, et al.
Oxygen consumption of respiratory muscles in patients with COPD.
Chest, 105 (1994), pp. 790-797
[54.]
D.F. Rochester.
The diaphragm in COPD: better than expected, but not good enough.
N Engl J Med, 325 (1991), pp. 961-962
[55.]
D.F. Rochester, N.M.T. Braun.
Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease.
Am Rev Respir Dis, 132 (1985), pp. 42-47
[56.]
V. Ninane, M. Gorini.
Adverse effect of hypeinflation on parasternal intercostals.
J Appl Physiol, 77 (1994), pp. 2.201-2.206
[57.]
G.A. Farkas, C. Roussos.
Diaphragm in emphysematous hamsters: sarcomere adaptability.
J Appl Physiol, 54 (1983), pp. 1.635-1.640
[58.]
H. Tada, H. Kato, T. Misawa, et al.
31 P-nuclear magnetic resonance evidence of abnormal skeltal muscle metabolism in patients with chronic lung disease and congestive heart failure.
Eur Res pir J, 5 (1992), pp. 163-169
[59.]
V. Ninane, F. Rypens, J.C. Yernault, et al.
Abdominal muscle use during breathing in patients with chronic airflow obstruction.
Am Rev Respir Dis, 146 (1992), pp. 16-21
[60.]
F. Bellemare, A. Grassino.
Forcé reserve of the diaphragm in pa tients with chronic obstructive pulmonary disease.
J Appl Phy siol, 55 (1983), pp. 8-15
[61.]
M.C. Aguar, J. Gea, X. Aran, et al.
Modificaciones de la activi dad mecánica del diafragma inducidas por la inhalación de CO, en pacientes con EPOC.
Arch Bronconeumol, 29 (1993), pp. 226-228
[62.]
M.J. Barranco, J. Cortijo, M.A. Ciscar, et al.
Efecto del Co2 sobre el diafragma de rata in vitro.
Arch Bronconeumol, 30 (1994), pp. 445-448
[63.]
D.F. Rochester.
Respiratory muscle weakness, pattem of breat hing, and CO, retention in chronic obstructive pulmonary disea se [editorial].
Am Rev Respir Dis, 143 (1991), pp. 901-903
[64.]
J.B. Martyn, R.H. Moreno, P.D. Pare, et al.
Measurement ot inspiratory muscle performance with incremental threshold loading.
Am Rev Respir Dis, 135 (1987), pp. 919-923
[65.]
D. Laporta, A. Grassino.
Assessment of transdiaphragmatic pres sure in humans.
J Appl Physiol, 58 (1985), pp. 1.469-1.476
[66.]
M.B. Reid, K.E. Haack, K.M. Franchek, et al.
Reactive oxygen in skeletal muscle. Intracelular oxidant kinetics and fatigue in vitro.
J Appl Physiol, 73 (1992), pp. 1.797-1.804
[67.]
Medical Research Council.
Committee on research into chronic bronchitis instructions for use of the questionnaire on respiratory symptoms.
WJ Holman, (1966),
[68.]
D.A. Mahier, D.H. Weinberg, C.K. Walls, et al.
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of tow new clinical indexes.
Chest, 85 (1984), pp. 751-758
[69.]
G. Borg.
Psychophysical basis of perceived exertion.
Med Sci Sport Exer, 14 (1982), pp. 377-381
[70.]
G.H. Guyatt, L.B. Berman, M. Towsend, et al.
A measure of quality of lite for clinical trias in chronic lung disease.
Thorax, 42 (1987), pp. 773-778
[71.]
P.W. Jones, F.H. Quirk, C.M. Bavesystock, et al.
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.
Am Rev Respir Dis, 145 (1992), pp. 1.321-1327
[72.]
R. Guell, P. Casan, M. Sangenís, et al.
Traducción española y vali dación de un cuestionario de calidad de vida en pacientes con en fermedad pulmonar obstructive crónica.
Arch Bronconeumol, 31 (1995), pp. 202-210
[73.]
R.A. Johnson, L.J. Rubin.
Non invasive evaluation of right ventricular function.
Clin Chest Med, 8 (1987), pp. 65-80
[74.]
C.M. Fletcher, R. Pto, C. Tinker, et al.
The natural history of chro nic bronchitis and emphysema. An 8 year study of early chronic obstructive lung disease in working men in London.
Oxford University Press, (1976),
[75.]
A.E. Carrili, B. Burrows, R.J. Knudson, et al.
Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation.
Am Rev Respir Dis, 135 (1987), pp. 794-799
[76.]
R. OPeto, F.E. Speizar, A.L. Cochrane, et al.
The relevance in adults of airflow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease.
Am Rev Respir Dis, 128 (1983), pp. 491-500
[77.]
K.M. Freud, A.J. Belanger, R.B. D’Agostino, et al.
The health risks of smoking: the Framingham Study: 34 years of follow-up.
Ann Epidemiol, 3 (1993), pp. 417-424
[78.]
D.S. Postma, H.J. Shniter.
Prognosis of chronic obstructive pulmo nary disease: the Dutch experience.
Am Rev Respir Dis, 140 (1989), pp. 100-105
[79.]
M.C. Fiore, S.S. Smith, D.E. Jorenby, et al.
Review. The effectiveness of the nicotine patch for smoking cessation.
A meta-analysis. Jama, 271 (1994), pp. 1.940-1.947
[80.]
C.A. Jiménez, J.M. González de la Vega, C. Escudero, et al.
Taba quismo.
Manuales SEPAR, Grupo Aula Médica, (1995),
[81.]
Medical Research Council Working Party.
Long-term domiciliary oxygen therapy in chronic hipoxic cor pulmonale complicating chronic bronchitis and emphysema.
[82.]
Nocturnal Oxygen Therapy Trial Group.
Continous or nocturnal oxygen therapy in hipoxemic chronic obstructive pulmonary di sease: a clinical trial.
Ann Intern Med, 93 (1980), pp. 391-398
[83.]
Normativa para la indicación.
empleo de la oxigenoterapia cró nica domiciliaria (OCD), Ed. Doyma S.A, (1985),
[84.]
E.C. Fletcher, D. Scott, W. Quien, et al.
Evolution of nocturnal oxyhemoglobin desaturation in patients with chronic obstructive pul monary disease and daytime PaO2 above 60 mmHg.
Am Rev Respir Dis, 144 (1991), pp. 401-405
[85.]
J.P. Derenne, B. Fleury, R. Pariente.
State of the art. Acute respira tory failure of chronic obstructive pulmonary disease.
Am Rev Respir Dis, 139 (1988), pp. 1.006-1.033
[86.]
A.S. Buist, B. Burrows, A. Cohen, et al.
Guidelines for the approach to the individual with severe hereditary alpha-1-antitrypsin deficiency. An official statement of the American Thoracic Society.
Am Rev Respir Dis, 140 (1989), pp. 1.494-1.497
[87.]
G.L. Snider.
Pulmonary disease in alpha-1-antitrypsin deficiency.
Ann Intern Med, 111 (1989),
[88.]
Alpha 1 antitrypsin deficiency.
Symposium.
Chest, 95 (1989), pp. 181-208
[89.]
Alpha 1 antitrypsin deficiency.
Usage of alpha 1 proteinase inhibitor concentrate in replacement therapy.
Am J Med, 84 (1988), pp. 1-90
[90.]
A. Dirkens, F. Madsen, C.S. Ulrik, et al.
A randomized placebo controlled pilot study of alpha 1 protease inhibitor replacement therapy monitored by daily spirometry [resumen].
Am Rev Res pir Dis, 147 (1993), pp. 352
[91.]
M. Miravitlles, R. Vidal, M. Torrella, et al.
Evaluación del trata miento sustitutivo del enfisema por déficit de alfa-1-antitripsina.
Arch Bronconeumol, 30 (1994), pp. 479-484
[92.]
R.F. Grossman, J.R. Maurer.
Pulmonary Considerations in transplantation for chronic obstructive pulmonary disease.
Clin Chest Med, 11 (1990), pp. 195-362
[93.]
G.A. Patterson.
Lung transplantation for chronic obstructive pulmonary disease.
Clin Chest Med, (1990), pp. 547-554
[94.]
J.D. Cooper, G.A. Patterson, R. Grossman, et al.
Double lung transplant for advanced chronic obstructive lung disease.
Am Rev Respir Dis, 139 (1989), pp. 303-307
[95.]
H. Mal, B. Andreassian, F. Pamela, et al.
Unilateral lung transplan tation in end stage pulmonary emphysema.
Am Rev Respir Dis, 140 (1989), pp. 797-802
[96.]
T.A. Raffin.
Double lung transplantation for severe cOPD: reversing the irreversible.
Am Rev Respir Dis, 139 (1989), pp. 300-301
[97.]
I. Ziment.
Pharmacologic therapy of obstructive airway disease.
Clin Chest Med, 11 (1990), pp. 461-486
[98.]
N.J. Gross.
Chronic obstructive pulmonary disease. Currents concepts and therapeutic approaches.
Chest, 97 (1990), pp. 19-23
[99.]
R. Jaeschke, G.H. Guyatt, D. Cook, et al.
The effect of increasing doses of beta agonists on airflow in patients with chronic airflow limitation.
Respir Med, 87 (1993), pp. 433-438
[100.]
M. Cazzola, G. Santangelo, A. Piccolo, et al.
Effect of salmeterol and formeterol in patients with chronic obstructive pulmonary disease.
Pulm Pharmacol, 7 (1994), pp. 103-107
[101.]
C.H. Suppli Urrik.
Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
Thorax, 50 (1995), pp. 750-754
[102.]
N.H. Gross, T.L. Petty, M. Friedman, et al.
Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis, 139 (1989), pp. 1.185-1.191
[103.]
N.J. Gross, M.S. Skoridin.
Antiholinergic antimuscarinic bronchodilators.
Am Rev Respir Dis, 129 (1984), pp. 856-870
[104.]
D.C. Flenley.
Chronic obstructive pulmonary disease.
Dis Month, 12 (1988), pp. 543-599
[105.]
P.A. Easton, C. Jadue, S. Dhingra, et al.
A comparison of the bronchodilating effects of a beta 2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence.
N Engl J Med, 315 (1986), pp. 735-739
[106.]
J.F. Karpel.
Bronchodilator responses to anticholinergic and beta adrenergic agents in acutye and stable COPD.
Chest, 99 (1991), pp. 871-876
[107.]
G.T. Fergurson, R.M. Cherniack.
Management of chronic obstruc tive pulmonary disease.
N Engl J Med, 328 (1993), pp. 1.017-1.022
[108.]
N. Gross, Z. Bankwala.
Effects of an anticholinergic bronchodila tor on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis, 136 (1987), pp. 1.091-1.094
[109.]
R. Bone, Combivent inhalation aerosol study group.
In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone.
An 85 day multicenter trial. Chest, 105 (1994), pp. 1.411-1.419
[110.]
J.P. Karpel, A. Kotch, M. Zinny, et al.
A comparison of inhaled ipatropium, oral theophylline plus inhaled betaagonist, and the com bination of all three in patient with COPD.
Chest, 105 (1994), pp. 1.089-1.094
[111.]
E.H. Bel, A.H. Zwinderman, M.C. Timmers, et al.
The protective effect of a beta-2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuly in asthma and chronic obstructive lung disease.
Thorax, 46 (1991), pp. 9-14
[112.]
S. Kesten, A.S. Rebuck, K.R. Champman.
Trends in asthma and chronic obstructive pulmonary disease therapy in Canada.
J Allergy Clin Immunol, 92 (1993), pp. 499-506
[113.]
D.A. Sclar, R.F. Legg, T.L. Skaer, et al.
Ipratropium bromide in the management of chronic obstructive pulmonary disease: effect on health service expenditures.
Clin Ther, 16 (1994), pp. 595-601
[114.]
D. Murciano, M.H. Auclair, R. Pariente, et al.
A randomized, con trolled trial of theophylline in patients with severe chronic obs tructive pulmonary disease.
N Engl J Med, 320 (1989), pp. 1.521-1.525
[115.]
J.W. Jenne.
What role for theophylinne therapy?.
Thorax, 49 (1994), pp. 97-100
[116.]
H. Lamont, M. Vander Stracten, R. Plauweis, et al.
The combined effect of theophylline and terbutaline in patients with chronic obstructive disease.
Eur J Respir Dis, 63 (1982), pp. 13-22
[117.]
G.E. Martin, B.J.S. Hatnett, N. Berend, et al.
Assessment of combined oral theophylline and inhaled beta 2 adrenoceptor agonist bronchodilator therapy.
Br J Clin Pharmacol, 5 (1978), pp. 45-50
[118.]
R.B. Filuk, P.A. Earton, N.R. Anthonisen.
Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis, 132 (1985), pp. 871-874
[119.]
S.A. Sahn.
Corticosteroids in chronic bronchitis and pulmonary emphysema.
Chest, 73 (1978), pp. 871-874
[120.]
C. Callaban, R.S. Dittus, B.P. Katz.
Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta analysis.
Ann Intern Med, 114 (1991), pp. 216-223
[121.]
R.K. Albert, T.R. Martin, S.W. Lewis.
Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency.
Ann Intern Med, 92 (1980), pp. 753-758
[122.]
T.E.J. Renkemar, H.J. Sluiter, G.H. Koeter, et al.
A two year prospective study on the effect of inhaled and inhaled plus oral corticos teroids in chronic airflow obstruction [resumen].
Am Rev Respir Dis, 141 (1990), pp. 504
[123.]
H.A.M. Kerstjen, P.L.P. Brand, M.D. Hughes, et al.
A comparison of bronchodilator therapy with or withoot inhaled Corticosteroids therapy for obstructive airways disease.
N Engl J Med, 327 (1992), pp. 1.413-1.419
[124.]
E. Dompeling, C.P. Van Schayck, P.V. Van Grunsven, et al.
Slowing the deterioration of asthma and chronic obstructive pulmo nary disease observed during bronchodilator therapy by adding inhaled Corticosteroids.
Ann Intern Med, 118 (1993), pp. 770-778
[125.]
S. Saint, S. Bent, E. Wittinghoff, et al.
Antibiotics in chronic obs tructive pulmonary disease exacerbations. A meta analysis.
JAMA, 273 (1995), pp. 957-960
[126.]
J.T. MacFarlane, R.G. Finh, M.D. Ward, et al.
Hospital study of adult community acquired pneumonia.
Lancet, 2 (1982), pp. 255-258
[127.]
D.C. Fedson.
Influenza and pneumococcal immunization strategies for physicians.
Chest, 91 (1987), pp. 436-443
[128.]
M.S. Simberkoff, A.P. Cross, M. Al Ibrahim, et al.
Efficacy of pneumo coccal vaccine in high risk patients: results of a Veterans Administrarion Cooperative Study.
N Engl J Med, 315 (1986), pp. 1.318-1.327
[129.]
Centers for disease control update: neumococcal polysacharide vaccine usage, United States. MMWR 1984; 33: 273-276-281. in press.
[130.]
J.F. Muir, D.J. Pierson, T.L. Petty, et al.
Pulmonary rehabilitation in chronic respiratory insufficiency, 49 (1994), pp. 279-280
[131.]
Güell, R. Rous, P. Casan Clara, J.A. García Besada, et al.
Número monográfico sobre rehabilitación respiratoria.
Arch Bronconeumol, 30 (1994), pp. 63-113
[132.]
Pulmonary Rehabilitation Research, NIH., Workshop Summary.
Am Rev Respir Dis, 49 (1994), pp. 825-893
[133.]
Casabury.
Principies and practice of pulmonary rehabilitation,
[134.]
B.R. Celli.
Pulmonary rehabilitation in patients with COPD.
Am J CritCareMed, 152 (1995), pp. 861-864
[135.]
M. Toshima, M. Kaplan, A.L. Ries.
Experimental evaluation of re habilitation in chronic obstructive pulmonary disease. Short term effects on excercise endurance and health status.
Health Psychol, 9 (1990), pp. 237-252
[136.]
R.S. Goldstein, E.H. Gork, M.A. Stubbing, et al.
Randomized control trial of respiratory rehabilitation.
Lancet, 344 (1994), pp. 1.394-1.397
[137.]
P.J. Wykstra, R. Van Altens, J. Kraan, et al.
Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home.
Eur Respir J, 7 (1994), pp. 269-273
[138.]
A.L. Ries, R.M. Kaplan, T.M. Limberg, et al.
Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in pa tients with chronic obstruction pulmonary disease.
Ann Intern Med, 122 (1995), pp. 823-832
[139.]
B.R. Celli, J. Rassulo, B.J. Make.
Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruc tion.
N Engl J Med, 314 (1986), pp. 1.483-1.490
[140.]
G.J. Criner, B.R. Celli.
Effect of unsupported arm exercise on ventilatory muscle recruitment in patients with severe chronic air flow obstruction.
Am Rev Respir Dis, 138 (1988), pp. 856-861
[141.]
A.L. Ries, B. Ellis, R.W. Hawkins.
Upper extremity exercise training in chronic obstructive pulmonary disease.
Chest, 93 (1988), pp. 688-692
[142.]
E.R. Lake, K. Henderson, T. Briffa, et al.
Upper limb and lower limb exercise training in patients with chronic airflow obstruc tion.
Chest, 97 (1990), pp. 1.077-1.082
[143.]
F.J. Martínez, P.D. Vogel, D.N. Dupont, et al.
Supported arm exerci se vs unsupported arm exercise in the rehabilitation of patients with chronic airflow obstruction.
Chest, (1993), pp. 1.397-1.402
[144.]
R. Casabury, A. Patessio, F. Ioli, et al.
Reduction in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung.
Am Rev Respir Dis, 143 (1991), pp. 9-18
[145.]
K. Wasserman, D.Y. Sue, R. Casaburi, et al.
Selection criteria for exercise training in pulmonary rehabilitation.
Eur Respir J, 2 (1989), pp. 604-610
[146.]
P.A. Punzal, A.I. Ries, R.M. Kaplan, et al.
Máximum intensity exer cise training in patients with chronic obstructive pulmonary dise ase.
Chest, 100 (1991), pp. 618-623
[147.]
C.F. Donner, P. Howard.
Pulmonary rehabilitation in chronic obs tructive pulmonary disease (COPD) with recomendations.
Eur Respir J, 5 (1992), pp. 226-275
[148.]
P.J. Vijkstra, E.M. Ten Vergert, R. Van Altena, et al.
Long term benefits of rehabilitation at home on quality of lite and exercise tolerance in patients with chronic obstructive pulmonary disease.
Thorax, 50 (1995), pp. 824-828
[149.]
S. Levine, P. Weiser, J. Guillen.
Evaluation ot a ventilatory muscle endurance training program in the rehabilitation of patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis, 133 (1986), pp. 400-406
[150.]
M.J. Belman, C. Mittman.
Ventilatory muscle training improves exercise capacity in COPD.
Am Rev Respir Dis, 121 (1980), pp. 273-280
[151.]
T.L. Clanton, G. Dixon, J. Drake, et al.
Inspiratory muscle training conditioning using a thresholdioading device.
Chest, 87 (1985), pp. 62-66
[152.]
R.L. Pardy, W.D. Reid, M.J. Belman.
Respiratory muscle training.
Clin Chest Med, 9 (1988), pp. 287-296
[153.]
K. Smith, D. Cook, G.H. Guyatt, et al.
Respiratory muscle training in chronic airflow limitation: a metaanalysis.
Am Rev Respir Dis, 145 (1992), pp. 533-539
[154.]
M.J. Belman, C. Warren, Botnick, et al.
Ventilatory load characteristics during ventilatory muscle training.
Am J Respir Crit Care Med, 149 (1994), pp. 925-991
[155.]
J. Bott, M.P. Carrol, J.H. Conway, et al.
Randomized controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease.
Lancet, 341 (1993), pp. 1.555-1.557
[156.]
J. Mancebo, S. Benito, A. Nett.
Efecto de la ventilación con pre sión de soporte con máscara facial en pacientes con insuficiencia respiratoria crónica en descompensación aguda.
Med Clin (Barc), 102 (1994), pp. 641-646
[157.]
L. Brochard, J. Mancebo, M. Wysocki, et al.
Noninvasive ventila tion for acute exacerbations of chronic obstructive pulmonary di sease.
N Engl J Med, 333 (1995), pp. 817-822
[158.]
G.U. Meduri, N. Abou-Shala, R.C. Fox, et al.
Noninvasive face mask mechanical ventilation in patients with acute hypercapnic respi ratory failure.
Chest, 100 (1991), pp. 445-454
[159.]
D.E. Sassi Drambon, E.G. Eakin, A.L. Ries, et al.
Treatment of dyspnea in COPD. A controlled clinical trial of dyspnea management strategies.
Chest, 107 (1995), pp. 724-729
[160.]
H.P. Wiedemann, R.A. Matthay.
Cor pulmonale in chronic obstructive pulmonary disease. Circulatory Pathophysiology and mana gement.
Clin Chest Med, 11 (1990), pp. 523-545
[161.]
L.J. Rubin.
Vasodilators and pulmonary hypertension where do we go from here?.
Am Rev Respir Dis, 135 (1987), pp. 288-293
[162.]
S. Adnot, C. Kouyoumdjian, C. Detbuilloy.
Hemodynamic and gas exchange responses to infusión of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive disease and pulmonary hypertension.
Am Rev Respir Dis, 148 (1993), pp. 310-316
[163.]
P.M. Dupuy, S.A. Shore, J.M. Drazen, et al.
Bronchodilators action of inhaled nitric oxide in guinnea pigs.
J Clin Invest, 90 (1992), pp. 421-428
[164.]
J.D. Brain.
Aerosol and humidity therapy.
Am Rev Respir Dis, 122 (1980), pp. 17-21
[165.]
Ch. Shim, M. King, M.H. Williams.
Lack of effects of hydratation on sputum production in chronic bronchitis.
Chest, 92 (1987), pp. 679-682
[166.]
Multicenter Study Group.
Long-term oral acetylcysteine in chro nic beonchitis, a double-blind controlled study.
Eur J Respir Dis, 111 (1980), pp. 93-108
[167.]
G. Boman, U. Backer, S. Larsson, et al.
Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized.by the Swedish Society for pulmonary diseases.
Eur J Respir Dis, 64 (1983), pp. 405-415
[168.]
T.L. Petty.
The National Mucolytic Study. Results of a randomi zed, double-blind placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis.
Chest, 97 (1990), pp. 75-83
[169.]
J. Izquierdo, J. Morera.
Respiratory stimulants and COPD [edito rial].
Am Rev Respir Dis, 12 (1994), pp. 1.003-1.005
[170.]
F. Arnaud, A. Bertrand, J. Charpin, et al.
Long-term almitrine bimesylate treatment in patients with chronic bronchitis and emphysema. A multicenter double blind placebo controlled study.
Eur J Respir Dis, 126 (1983), pp. 323-330
[171.]
R.C. Bell, R.C. Mulling, L.G. West, et al.
The effect of almitrine bismesylate on hipoxemia in chronic obstructive pulmonary disea se.
Ann Intern Med, 105 (1986), pp. 342-346
[172.]
P. Escourron, G. Simonneau, J.C. Ausquer, et al.
A single orally administered dose of almitrine improves pulmonary gas exchange during exercise in patients with chronic airflow obstruction.
Am Rev Respir Dis, 133 (1986), pp. 562-567
[173.]
P. Herve, D. Musset, G. Simonneau, et al.
Almitrine decreases the distensibility of the large pulmonary arteries in man.
Chest, 96 (1989), pp. 572-577
[174.]
M. Ferrer, J. Alonso, J.M. Antó, et al.
The Spanich version of the St. George's Respiratory Questionnaire (SGRQ): adaptation and preliminary validity.
Eur Respir J, 8 (1995), pp. 54
[175.]
S.L. Kanford, M.C. Fiore, D.E. Jorenby, et al.
Predicting smoking cessation: who will quit with and without the nicotine patch.
JAMA, 271 (1994), pp. 589-594
[176.]
G.N. Olsen.
The evolving role of exercise testing prior to lung resection.
Chest, 95 (1989), pp. 218-225
[177.]
A. Bautista.
Factores que inciden en la descompensación de la en fermedad pulmonar obstructiva crónica..
EPOC, perspectivas actuales, pp. 73-87
[178.]
P.W. Jones, T.K. Bosh.
Improvement in quality of life in COPD patients treated with sameterol.
Am J Respir Crit Care Med, 151 (1995), pp. 464
[179.]
M. Friedman.
Changing practices in COPD. A new pharmacologic treatment algorithm.
Chest, 107 (1995), pp. 194-197
[180.]
D.P. Tashkin.
Multiple dose regimens. Impact on compliance.
Chest, 107 (1995), pp. 176-182
[181.]
T. Montemayor.
Rehabilitación respiratoria en la EPOC.
En EPOC, perspectivas actuales. Madrid: Aula Médica, (1995), pp. 91-125
[182.]
N.R. Anthunisen, J.E. Connett, J.P. Kiley, et al.
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1.
JAMA, 272 (1994), pp. 1.497-1.505
[183.]
N.M. Siafakas, et al.
ERS Consensus Statement Optimal assessment and management of chronic obstructive pulmonary disease (COPD).
Eur Respir J, 8 (1995), pp. 1.398-1.420
[184.]
B.R. Celli, et al.
American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmo nary disease.
Am J Respir Crit Care Med, 152 (1995), pp. 77-120

Coordinador: Rubio. Hospital Universitario Virgen del Rocío. Sevilla.

Copyright © 1996. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología

Subscribe to our newsletter

Article options
Tools

Are you a health professional able to prescribe or dispense drugs?